These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24487023)

  • 1. Effects of AMPK activation on insulin sensitivity and metabolism in leptin-deficient ob/ob mice.
    Zachariah Tom R; Garcia-Roves PM; Sjögren RJ; Jiang LQ; Holmström MH; Deshmukh AS; Vieira E; Chibalin AV; Björnholm M; Zierath JR
    Diabetes; 2014 May; 63(5):1560-71. PubMed ID: 24487023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle-specific overexpression of wild type and R225Q mutant AMP-activated protein kinase gamma3-subunit differentially regulates glycogen accumulation.
    Yu H; Hirshman MF; Fujii N; Pomerleau JM; Peter LE; Goodyear LJ
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E557-65. PubMed ID: 16638825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of leptin treatment on mitochondrial function in obese leptin-deficient ob/ob mice.
    Holmström MH; Tom RZ; Björnholm M; Garcia-Roves PM; Zierath JR
    Metabolism; 2013 Sep; 62(9):1258-67. PubMed ID: 23664724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective leptin-AMP-dependent kinase pathway induces nitric oxide release and contributes to mitochondrial dysfunction and obesity in ob/ob mice.
    Finocchietto PV; Holod S; Barreyro F; Peralta JG; Alippe Y; Giovambattista A; Carreras MC; Poderoso JJ
    Antioxid Redox Signal; 2011 Nov; 15(9):2395-406. PubMed ID: 21529143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain-of-function R225Q mutation in AMP-activated protein kinase gamma3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle.
    Garcia-Roves PM; Osler ME; Holmström MH; Zierath JR
    J Biol Chem; 2008 Dec; 283(51):35724-34. PubMed ID: 18838377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
    Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in exercise-induced gene expression in 5'-AMP-activated protein kinase gamma3-null and gamma3 R225Q transgenic mice.
    Barnes BR; Long YC; Steiler TL; Leng Y; Galuska D; Wojtaszewski JF; Andersson L; Zierath JR
    Diabetes; 2005 Dec; 54(12):3484-9. PubMed ID: 16306365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5'-AMP-activated protein kinase gamma3 isoform has a key role in carbohydrate and lipid metabolism in glycolytic skeletal muscle.
    Barnes BR; Marklund S; Steiler TL; Walter M; Hjälm G; Amarger V; Mahlapuu M; Leng Y; Johansson C; Galuska D; Lindgren K; Abrink M; Stapleton D; Zierath JR; Andersson L
    J Biol Chem; 2004 Sep; 279(37):38441-7. PubMed ID: 15247217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK and ACC phosphorylation: effect of leptin, muscle fibre type and obesity.
    Janovská A; Hatzinikolas G; Staikopoulos V; McInerney J; Mano M; Wittert GA
    Mol Cell Endocrinol; 2008 Mar; 284(1-2):1-10. PubMed ID: 18255222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal muscle AMP-activated protein kinase γ1(H151R) overexpression enhances whole body energy homeostasis and insulin sensitivity.
    Schönke M; Myers MG; Zierath JR; Björnholm M
    Am J Physiol Endocrinol Metab; 2015 Oct; 309(7):E679-90. PubMed ID: 26306597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females.
    Steinberg GR; Smith AC; Van Denderen BJ; Chen Z; Murthy S; Campbell DJ; Heigenhauser GJ; Dyck DJ; Kemp BE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4575-80. PubMed ID: 15356065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification.
    Tanaka T; Hidaka S; Masuzaki H; Yasue S; Minokoshi Y; Ebihara K; Chusho H; Ogawa Y; Toyoda T; Sato K; Miyanaga F; Fujimoto M; Tomita T; Kusakabe T; Kobayashi N; Tanioka H; Hayashi T; Hosoda K; Yoshimatsu H; Sakata T; Nakao K
    Diabetes; 2005 Aug; 54(8):2365-74. PubMed ID: 16046303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of AMPK activation in leptin- and creatine-deficient mice.
    Stockebrand M; Sauter K; Neu A; Isbrandt D; Choe CU
    FASEB J; 2013 Oct; 27(10):4147-56. PubMed ID: 23825223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans.
    Steinberg GR; McAinch AJ; Chen MB; O'Brien PE; Dixon JB; Cameron-Smith D; Kemp BE
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3592-7. PubMed ID: 16822822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice.
    O'Neill HM; Lally JS; Galic S; Thomas M; Azizi PD; Fullerton MD; Smith BK; Pulinilkunnil T; Chen Z; Samaan MC; Jorgensen SB; Dyck JR; Holloway GP; Hawke TJ; van Denderen BJ; Kemp BE; Steinberg GR
    Diabetologia; 2014 Aug; 57(8):1693-702. PubMed ID: 24913514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle.
    Dobrzyn A; Dobrzyn P; Lee SH; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E599-607. PubMed ID: 15562249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic central leptin decreases food intake and improves glucose tolerance in diet-induced obese mice independent of hypothalamic malonyl CoA levels and skeletal muscle insulin sensitivity.
    Keung W; Palaniyappan A; Lopaschuk GD
    Endocrinology; 2011 Nov; 152(11):4127-37. PubMed ID: 21914780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits.
    Treebak JT; Glund S; Deshmukh A; Klein DK; Long YC; Jensen TE; Jørgensen SB; Viollet B; Andersson L; Neumann D; Wallimann T; Richter EA; Chibalin AV; Zierath JR; Wojtaszewski JF
    Diabetes; 2006 Jul; 55(7):2051-8. PubMed ID: 16804075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
    Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
    Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.